Search Results

Molecularly Informed Lung Cancer Treatment in a Community Cancer Network: A Pragmatic Consortium and Longitudinal Prospective Study (MYLUNG Program: Part 3) Order-Set-Go: Increasing Biomarker Testing Rates in Patients with Non-small-cell Lung Cancer Through Use of Clinical Decision Support Tools (MYLUNG/23329/LUN 576) Brief Summary: This longitudinal study looks to quantify the testing timeline, operational barriers, and…

An Open-label, Multi-Center, Phase 2 Clinical Trial Evaluating Sapanisertib and Serabelisib (PIKTOR) with Paclitaxel, and a Substudy Evaluating PIKTOR with Paclitaxel plus an Insulin-Suppressing Diet, in Patients with Advanced or Recurrent Endometrial Cancer (FTH-PIK-201) MOA: PIKTOR is a combination of sapanisertib, an mTORC1 and 2 inhibitor, and serabelisib, a PI3Kα inhibitor. Key Eligibility Criteria: Histologically…

Ariuka Arya is a nurse practitioner with over six years of experience as a registered nurse across adult ICU, trauma, and cardiac testing settings. She received her Bachelor of Science in Nursing from George Mason University and her Master of Science in Nursing as a family nurse practitioner from the University of Alabama at Birmingham.…

Mature cancer care patient Tremendous advances are made every day in the fight against cancer, but many promising treatments are costly, placing patients under enormous financial pressure. The challenges of increasing premiums, deductibles, and copayments affect many, with up to 61% of cancer patients facing difficulties in their care.1 Patients in Maryland Have a Choice in Cancer…